Friday, 15 Feb 2019

You are here

Weight Loss Lessens Knee Pain in Obese

Obese knee osteoarthritis (OA) patients who lose > 20% of their weight were in significantly less pain, had better function and improved quality of life. 

A study in Arthritis Care & Research reports the results of a secondary analysis from the Intensive Diet and Exercise for Arthritis (IDEA) study that included 240 overweight and obese adults with pain and radiographic knee OA. Patients were randomized to one of 4 groups and followed for an 18‐month period. (Citation source: bit.ly/2ymt6UI)

A significant dose responses to weight loss was achieved for pain reduction (p = 0.01), function (p = 0.0006), 6‐minute walk distance (p < 0.0001), quality of life (HRQL), knee joint compressive force (p < 0.0001), and IL‐6 (p = 0.002).

Greater weight loss resulted in superior clinical and mechanstic outcomes with the highest weight loss group (≥20% group) distinguishing itself on all measures compared to the <5% and ≥5% groups; the ≥20% group had 25% less pain and better function than the ≥ 10% group, and significantly (p = 0.006) better physical HRQL.

Overall 10% or more weight loss resulted in a 50% reduction in pain, and patients also reported significant improvements in mobility and daily function. 

It is unclear what the long-term effects of weight loss on knee joint pain or mobility will be from this study. 

Weight loss not only improved knee pain, but also was shown to decrease inflammation with lower IL-6 levels.

 

 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Pain Drives the Use of Medical Marijuana

A report from the University of Michigan examined state-wide medical marijuana showing most of it is used for chronic pain.

The authors include Kevin Boehnke, Ph.D., Daniel J. Clauw, M.D., Rebecca L. Haffajee, Ph.D., and Saurav Gangopadhyay, M.P.H. undertook this investigation to to assess why people are using cannabis medically. 

Compounded Pain Creams - Expensive Placebos?

The Annals of Internal Medicine reports that the growth and use of compounded pain creams is unwarranted as they were no better than placebo in a randomized controlled trial, suggesting their higher costs are unjustifiable compared to other topical commercially available agents (lidocaine, diclofenac, capsaicin, etc.). (Citation source: https://buff.ly/2BkTj58)

Opioids Double Rates of Suicides and Overdoses

An article in the New England Journal of Medicine reports that the rates of suicide and drug overdoses has doubled in the last 17 years, and that opioids are largely to blame.

Using data from the Centers for Disease Control and Prevention databases, researchers show that the sheer number of deaths from suicides and unintentional overdoses together rose from 41,364 in the year 2000 to 110,749 in 2017.

Cryotherapy Never FDA Approved

Another injury related to whole body cryotherapy (WBC) has been reported by practitioners in Philadelphia, serving as yet another warning of WBC's potential to cause serious adverse effects.

Post-Approval Exploratory Trials with Pregabalin Often Fail

A systematic review of 238 pregabalin (Lyrica) trials for nonapproved indications shows that nearly two-thirds yielded uncertain evidence of efficacy, thereby questioning the off-label use or endorsement in clinical practice guidelines.